These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29255368)

  • 1. Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction.
    Gruzdeva O; Uchasova E; Dyleva Y; Akbasheva O; Karetnikova V; Shilov A; Barbarash O
    Diabetes Metab Syndr Obes; 2017; 10():481-489. PubMed ID: 29255368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effects of atorvastatin on myocardial infarction.
    Barbarash O; Gruzdeva O; Uchasova E; Belik E; Dyleva Y; Karetnikova V
    Drug Des Devel Ther; 2015; 9():3361-8. PubMed ID: 26170622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance.
    Gruzdeva O; Uchasova E; Belik E; Dyleva Y; Shurygina E; Barbarash O
    BMC Cardiovasc Disord; 2014 Jan; 14():7. PubMed ID: 24433403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction.
    Gruzdeva O; Uchasova E; Dyleva Y; Akbasheva O; Karetnikova V; Barbarash O
    Front Pharmacol; 2016; 7():324. PubMed ID: 27725801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid, adipokine and ghrelin concentrations in myocardial infarction patients with insulin resistance].
    Gruzdeva OV; Karetnikova VN; Akbasheva OE; Fedorova TS; Belik EV; Palicheva EI; Uchasova EG; Dyleva IuA; Brazovskaia NG; Barbarash OL
    Vestn Ross Akad Med Nauk; 2013; (7):13-9. PubMed ID: 24340956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of atorvastatin in improving the inflammation-induced adipokine imbalance in mice with acute myocardial infarction].
    Chen L; Li R; Huang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 42(7):790-795. PubMed ID: 28845002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation Activation Contributes to Adipokine Imbalance in Patients with Acute Coronary Syndrome.
    Li R; Chen LZ; Zhao SP; Huang XS
    PLoS One; 2016; 11(3):e0151916. PubMed ID: 26986475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study).
    Khera AV; Qamar A; Murphy SA; Cannon CP; Sabatine MS; Rader DJ
    Am J Cardiol; 2015 Sep; 116(5):694-8. PubMed ID: 26119654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
    Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokines Levels in Patients With Coronary Artery Disease and Diabetes Mellitus].
    Koshel'skaia OA; Vinnitskaia IV; Konko TIu; Kravchenko ES; Suslova TE; Karpov RS
    Kardiologiia; 2015; 55(3):67-74. PubMed ID: 26320293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ghrelin level and TNF-α/ghrelin ratio in patients with previous myocardial infarction.
    Vörös K; Prohászka Z; Kaszás E; Alliquander A; Terebesy A; Horváth F; Janik L; Sima A; Forrai J; Cseh K; Kalabay L
    Arch Med Res; 2012 Oct; 43(7):548-54. PubMed ID: 23079033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction.
    Barbarash O; Gruzdeva O; Uchasova E; Dyleva Y; Belik E; Akbasheva O; Karetnikova V; Kokov A
    Diabetol Metab Syndr; 2016; 8():24. PubMed ID: 26989445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs.
    Farooq R; Amin S; Hayat Bhat M; Malik R; Wani HA; Majid S
    Gynecol Endocrinol; 2017 Jan; 33(1):75-78. PubMed ID: 27705028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atorvastatin on pancreatic Beta-cell function and insulin resistance in type 2 diabetes mellitus patients: a randomized pilot study.
    Goyal A; Singh S; Tandon N; Gupta N; Gupta YK
    Can J Diabetes; 2014 Dec; 38(6):466-72. PubMed ID: 24933106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.
    Nyström T; Nygren A; Sjöholm A
    Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and With Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokynes Levels in Patients With Coronary Artery Disease and Diabetes Mellitus].
    Koshelskaya OA; Vinnitskaya IV; Konko TY; Kravchenko ES; Suslova TE; Karpov RS
    Kardiologiia; 2015 Mar; 55(3):67-74. PubMed ID: 28294846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
    Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance].
    Stochmal A; Jasiak-Tyrkalska B; Stochmal E; Huszno B; Kawecka-Jaszcz K
    Przegl Lek; 2007; 64(6):410-5. PubMed ID: 18159849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study.
    Barbarash O; Gruzdeva O; Uchasova E; Belik E; Dyleva Y; Karetnikova V
    Arch Med Sci; 2017 Mar; 13(2):311-320. PubMed ID: 28261283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction.
    Lindberg S; Jensen JS; Pedersen SH; Galatius S; Frystyk J; Flyvbjerg A; Bjerre M; Mogelvang R
    Diabetes Care; 2014 Nov; 37(11):3003-8. PubMed ID: 25078899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.